Dacarbazine and Pneumothorax - a phase IV clinical study of FDA data

Summary:

Pneumothorax is reported as a side effect among people who take Dacarbazine (dacarbazine), especially for people who are male, 20-29 old, have been taking the drug for 1 - 6 months also take Bleomycin Sulfate, and have Hodgkin's lymphoma.

The phase IV clinical study analyzes which people have Pneumothorax when taking Dacarbazine. It is created by eHealthMe based on reports of 8,052 people who have side effects when taking Dacarbazine from the FDA, and is updated regularly.

What is Dacarbazine?

Dacarbazine has active ingredients of dacarbazine. eHealthMe is studying from 8,064 Dacarbazine users. Check the latest studies of Dacarbazine.

What is Pneumothorax?

Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung) is found to be associated with 1,250 drugs and 1,345 conditions by eHealthMe. Check the latest studies of Pneumothorax.

On Jul, 21, 2026

8,052 people reported to have side effects when taking Dacarbazine.
Among them, 54 people (0.67%) have Pneumothorax.

Among these 54 people:

How long have people been on Dacarbazine when they have Pneumothorax? *

What is the gender of people who have Pneumothorax when taking Dacarbazine? *

female: 39.22 %
male: 60.78 %

What is the age of people who have Pneumothorax when taking Dacarbazine? *

What are other drugs people take besides Dacarbazine? *

What are other side effects people have besides Pneumothorax? *

Dyspnea (difficult or laboured breathing): 12 people, 22.22%
Pneumonia: 11 people, 20.37%
Pneumomediastinum (air is present in the mediastinum): 11 people, 20.37%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 11 people, 20.37%
Arrhythmias (irregular heartbeat): 10 people, 18.52%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 10 people, 18.52%
Pulmonary Toxicity (side effects on the lungs): 9 people, 16.67%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 9 people, 16.67%
Acute Respiratory Failure: 9 people, 16.67%
Subcutaneous Emphysema (smooth bulging of the skin): 8 people, 14.81%

What are the existing conditions these people have? *

Hodgkin's Lymphoma (cancer originating from white blood cells): 24 people, 44.44%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 6 people, 11.11%
Oropharyngeal Pain: 6 people, 11.11%
Bone Marrow Conditioning Regimen: 3 people, 5.56%
Hodgkin's Disease Stage Iii (cancer originating from white blood cells - stage iii): 3 people, 5.56%
Uterine Leiomyosarcoma (uterus cancer of smooth muscle connective tissue): 2 people, 3.70%
Synovial Sarcoma (tumour of synovial membrane of joint): 2 people, 3.70%
Hodgkin's Disease Nodular Sclerosis Stage Iv (cancer originating from white blood cells- stage iv): 2 people, 3.70%
Hodgkin's Disease Nodular Sclerosis Stage Unspecified (cancer originating from white blood cells -unspecified): 2 people, 3.70%
Angiosarcoma (cancer of endothelial-type cells that line vessel walls): 2 people, 3.70%

* Approximation only. Some reports may have incomplete information.

Do you take Dacarbazine and have Pneumothorax?

- Check whether Pneumothorax is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dacarbazine:

Dacarbazine (8,064 reports)

Pneumothorax treatments and more:

Pneumothorax (19,143 reports)

Browse all side effects of Dacarbazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pneumothorax:

Pneumothorax (1,250 drugs)

Browse all the conditions that are associated with Pneumothorax:

Pneumothorax (1,345 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dacarbazine (the active ingredients of Dacarbazine) and Dacarbazine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.